Arkansas
Little Rock; Arkansas Children's Hospital
Research Institute
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
California
Santa Ana; Clinical Innovations
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Florida
Gainesville; Sarkis Clinical Trials
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Georgia
Decatur; Northlake Medical Research Ctr.
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Kansas
Overland Park; Psychiatric Associates
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Maine
Bangor; Acadia Hospital
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Maryland
Baltimore; Pharmasite Research, Inc.
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Massachusetts
Boston; Massachusetts General Hospital (MGH)
A Pilot Open Study of the Safety and Effectiveness of Lamotrigine for the Treatment of Mania in Youth ages 6-17 with Bipolar I, Bipolar II, and Bipolar Spectrum Disorders
Boston; Massachusetts General Hospital (MGH)
Pilot Treatment Study of Fluoxetine for Obsessive-Compulsive Disorder in Children and Adolescents with Bipolar Disorder
North Carolina
Chapel Hill; North Carolina Neuropsychiatry, PA
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
North Dakota
Fargo; Odyssey Research
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Ohio
Canton; Neuro Behavioral Clinical Research, Inc.
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Neuroimaging and Neurocognitive Testing of Children and Adolescents with Bipolar Disorder.
Cincinnati; Cincinnati Children's Hospital Medical Center/Cincinnati Children's Research Foundation
Early-Onset Bipolar Medication Study
Cincinnati; Psychiatric Professional Services
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Cleveland; Discovery & Wellness Center for Children
Talk Therapy for the Treatment of Bipolar Disorder Symptoms in Youth
Cleveland; Discovery & Wellness Center for Children
Aripiprozole in At-Risk Children with symptoms of Bipolar Disorder
Lyndhurst; Rakesh Ranjan, MD & Associates, Inc.
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Tennessee
Memphis; UTHSC, Dept. of Psychiatry,
College of Medicine
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Texas
DeSoto; InSite Clinical Research
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
Washington
Bellevue; Northwest Clinical Research Center
A 6-month open-label clinical research study to evaluate the safety of Depakote ® ER in the treatment of mania associated with Bipolar I Disorder in children and adolescents.
